Checked Nov 14, 2026Start a new check

What was checked

New study shows ketogenic diet therapy led to 56% lower major cardiac events (heart attack, stroke, death) over up to 8 years vs usual care in diabetes/obesity patients

Assessment summary

Needs caution

This contains some claims that could not be fully verified or may be partially inaccurate. The assessments differed — review each one below for details.

Key findings

Model assessments

Assessment summary

The 56% figure and follow-up duration are reported in a 2026 retrospective claims-based study of a telemedicine carbohydrate-reduction program.link.springer.com However, the study was observational, so it shows an association rather than proving that ketogenic therapy caused fewer cardiac events.link.springer.com x.com Broader reviews describe cardiovascular-outcome evidence for ketogenic diets as limited, mixed, and mostly low certainty.link.springer.com

Claims reviewed

The intervention was specifically a ketogenic diet therapy.

Needs context
The intervention was an individualized carbohydrate-reduced nutrition program delivered by telemedicine and targeting nutritional ketosis; the study design cannot isolate the effects of ketosis from the broader program, clinical support, or other differences.link.springer.com x.com

This claim may mislead readers without added context.

The study establishes that ketogenic diet therapy caused a 56% reduction in major cardiac events.

Needs context
The research was retrospective and observational, using claims data and matched controls rather than random assignment. It supports an association, not a causal treatment effect.link.springer.com x.com

This claim may mislead readers without added context.

The outcome was observed over up to 8 years.

Supported
The reported claims-based follow-up extended for up to eight years.link.springer.com x.com

Assessment summary

  • The 56% reduction in major cardiac events is accurate for the specific outcome measured (3-point MACE), but the claim overstates the follow-up duration.
  • The study had a median follow-up of approximately 2 years, not "up to 8 years." While the study population included diabetes/obesity patients and compared to usual care, the timeframe claim is significantly misleading.

Claims reviewed

follow-up duration of up to 8 years

Contradicted
The cardiovascular outcomes study had a median follow-up of approximately 2 years, not up to 8 years medrxiv.org. While some other carbohydrate-restricted diet studies have follow-up durations up to 8 years, this specific cardiovascular outcomes study did not medrxiv.org.

This claim may mislead readers without added context.

ketogenic diet therapy led to 56% lower major cardiac events

Supported
The recent telemedicine study found a 56% lower risk of 3-point MACE (heart attack, stroke, death) in the intervention group receiving carbohydrate-reduced nutrition therapy link.springer.com.

major cardiac events defined as heart attack, stroke, death

Supported
The study defines 3-point MACE as nonfatal myocardial infarction, nonfatal stroke, or all-cause death, which matches the claim link.springer.com.

Assessment summary

  • The paper reports a 56% lower rate of a three-point major adverse cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, or all-cause death) in participants receiving a telemedicine carbohydrate-restricted (ketogenic-targeted) program versus matched usual-care controls.
  • The result covers follow-up up to eight years in this retrospective claims-based cohort and the paper explicitly describes the intervention as telemedicine-delivered therapeutic carbohydrate restriction (Virta-style), not a randomized controlled trial.

Claims reviewed

Ketogenic diet therapy led to 56% lower major cardiac events (heart attack, stroke, death) over up to 8 years vs usual care in diabetes/obesity patients

Supported
The published retrospective claims-based cohort reports a 56% lower incidence of MACE-3 (nonfatal MI, nonfatal stroke, or all-cause death) for participants in a telemedicine carbohydrate-reduction program versus propensity-score matched usual-care controls, with follow-up up to eight years. The study is observational and uses claims data rather than randomized assignment, which affects causal interpretation. link.springer.com

Sources cited

14 sources

Share this result